These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25227983)

  • 41. Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset.
    Komura K; Sato S; Fujimoto M; Hasegawa M; Takehara K
    Rheumatology (Oxford); 2002 Oct; 41(10):1149-54. PubMed ID: 12364635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
    Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of some biochemical markers as prognostic factors in malignant lymphoma.
    Khalifa KA; Alkilani AA; Ismail H; Soliman MA
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):47-54. PubMed ID: 19847281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
    Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
    Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
    Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunophenotypic characteristics of children with acute lymphoblastic leukemia carrying TEL-AML1 fusion gene].
    Liu Y; Li ZG; Zhao W; Li B; Gong WY; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):714-6. PubMed ID: 16928306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
    Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
    Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
    Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
    Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
    Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.
    Sabaawy HE; Azuma M; Embree LJ; Tsai HJ; Starost MF; Hickstein DD
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15166-71. PubMed ID: 17015828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High expression of cytoskeletal protein drebrin in TEL/AML1pos B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody.
    Vaskova M; Kovac M; Volna P; Angelisova P; Mejstrikova E; Zuna J; Brdicka T; Hrusak O
    Leuk Res; 2011 Aug; 35(8):1111-3. PubMed ID: 21497902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
    Wu S; Korte A; Gessner R; Henze G; Seeger K
    Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies.
    Porcel JM; Esquerda A; Rodriguez-Panadero F; Martínez-Iribarren A; Bielsa S
    J Thorac Oncol; 2011 Jan; 6(1):190-4. PubMed ID: 21079519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significant elevation of tumour-associated isoforms of soluble CD44 in serum of normal individuals caused by cigarette smoking.
    Kittl EM; Ruckser R; Rech-Weichselbraun I; Hinterberger W; Bauer K
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):81-4. PubMed ID: 9056747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
    Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
    Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
    Dong WG; Sun XM; Yu BP; Luo HS; Yu JP
    World J Gastroenterol; 2003 Nov; 9(11):2596-600. PubMed ID: 14606105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.